TABLE 4.
Considerations for Management of Ketosis/DKA
STICH (20) | International Consensus (18) | STOP DKA (19) | Anne L. Peters’ Protocol (14) | EMA Guidance (11,12) | NICE Guidance (21–23) | |
---|---|---|---|---|---|---|
Stages of ketonemia/DKA by ketone level (BHB), mmol/L, or ketonuria | • >3.0 or significant ketonuria (more than ++): DKA | • 0.6–1.5 or trace/small/+ urine reading: ketonemia | • <1.0: normal or mild | • 0.6 mmol/L: ketonemia | • 0.6–1.5 or trace/small/+ urine reading: ketonemia | NA |
• 1.6–3.0 or moderate/++ urine reading: impending DKA | • 1.0–1.4: moderate | • >1.5–3.0 or moderate/++ urine reading: impending DKA | ||||
• >3.0 or large/very large/+++/++++: probable DKA | • 1.5–2.9: high | • >3.0 or large/very large/+++/++++ urine reading: probable DKA | ||||
• ≥3: extreme | ||||||
Other measures of DKA | • Blood glucose >200 mg/dL | NA | NA | NA | NA | NA |
• Bicarbonate <15.0 mmol/L | ||||||
• Venous pH <7.3 | ||||||
Stopping SGLT2i | When high ketones are detected, stop SGLT2i for a few days | When elevated ketones are present, discontinue SGLT2i until ketones are back to baseline | Stop SGLT2i when DKA symptoms (lethargy, loss of appetite, nausea, abdominal pain) are present | If any signs/symptoms of physical illness occur, stop SGLT2i and test ketones | • Stop SGLT2i if BHB >1.5 mmol/L or at moderate/++ urine ketone reading | • Assess A1C after 6 months and regularly thereafter; if no sustained improvement in glycemic control (>0.3% drop in A1C), stop dapagliflozin |
• Stop SGLT2i if ketone levels persist and symptoms are still present with ketonemia | • Stop at eGFR consistently <40 mL/min/1.73 m2 | |||||
Carbohydrate and fluid intake | • 30–60 g carbohydrates | • Ketonemia: 15–30 g carbohydrates; 300–500 mL fluids hourly | • 30–60 g carbohydrates | • If ketones >0.6 mmol/L, increase carbohydrate intake, give more insulin, drink fluids, and hold SGLT2i until back to baseline | • Patient may need to drink water | NA |
• 200–500 mL fluids hourly | • Impending DKA: same as above; also consider seeking medical attention | • 200–500 mL fluids hourly | • Monitor until ketones return to normal | • Extra carbohydrates should be taken if blood glucose is normal or low | ||
• Probable DKA: seek immediate medical attention | • Also depends on blood glucose | |||||
Correction insulin | 1.5 times the usual dose | Based on carbohydrate intake | • Moderate or higher ketones: consider increasing basal insulin by 20–50% until return to baseline | See description in text; give carbohydrates + correction dose; 1.5 times the usual correction dose if >200 mg/dL | Need to take extra rapid-acting insulin | NA |
• Calculate specific correction bolus insulin based on blood glucose and ketone level or use daily dosage calculation based on Table 6B in the STOP DKA report (19) | ||||||
Frequency of additional correction insulin and carbohydrates | Every 1–2 hours | Every hour | Every 2–4 hours | Every 1–2 hours | NA | NA |
Frequency of ketone checks during ketosis/DKA | Every 2–4 hours | If BHB >0.6 mmol/L, every 3–4 hours until resolution | Every 2–4 hours | Every 1–2 hours | 2 hours after initial check | NA |
Frequency of glucose checks during ketosis/DKA | NA | Frequently | Every 2–4 hours | Every 1–2 hours with ingestion of carbohydrates and fluids | Check glucose levels frequently to avoid hyperglycemia or hypoglycemia | NA |
When to seek medical attention | • Ketone levels >3.0 mmol/L, any management steps cannot be followed, or ketonemia does not resolve in 4–6 hours | • At “probable DKA” BHB or urine reading | • If high levels of ketones persist despite extra insulin and/or increased carbohydrate intake over a period of 6–10 hours | • If unable to keep down fluids, go to emergency department; otherwise, contact HCP if ketones are increasing and not responding to treatment within 1–2 hours | >3.0 or large/very large/+++/++++ urine reading | NA |
• If there are symptoms of | • If DKA symptoms and/or ketones are worsening | • If vomiting | • Always contact HCP if in doubt | |||
DKA, including abdominal pain, nausea, vomiting, fatigue, and/or dyspnea | • If unable to keep down fluids | |||||
• If there are persistent symptoms of DKA |
SGLT2i, SGLT2 inhibitor.